ARCHIVES

Capitated Oncology Becomes Marketplace Reality Wit Plan By Companies

This article is from The Cancer Letter archive.

Vol. 20 No. 02 | January 14, 1994

Download PDF Visit The Full Archive

Related Articles

ODAC Oks Melphalan Injection WR-2721 Needs More Data

February 7, 1992

In Brief: Karen Antman And John Glick lead ASCO; ODAC to Meet June 7 On Tamoxifin Trial

May 27, 1994

Low Dose Therapy Improves Survival Of Multiple Myeloma, ECOG Finds; Update At ASCO

May 25, 2007

NCI Moves To Suspend Researcher Amid Charges Contractor Made Mortgage And Other Payments

May 4, 1990

On Biomedical Malthusianism; Varmus, et al. Propose a Strategy For Saving Biomedical Research

May 2, 2014

NCI Cooperative Group, Cancer Center Trials Listed

November 28, 2008